Pfizer has announced that babies will likely need three vaccines against Covid after a preliminary analysis found 2- to 4-year-olds didn’t have as strong an immune response as expected to the very low-dose shots the company is testing on the youngest children.
Pfizer and its partner BioNTech said if the three-dose study is successful, they plan to apply for emergency authorization sometime in the first half of 2022 the Associated Press reports.
Currently, numerous countries are preparing to administer a child’s dose of the Covid-19 vaccine to children aged five and up with Ireland to begin the jabbing of primary school aged children in Christmas week.
Tell us your thoughts in the Facebook post and share this with your friends.
